Search

Author/Creator Jacobsen, S.

4. SAT0199 An estimate of the proportion of patients with sle receiving off-label treatment with rituximab in european countries. (23rd January 2014)

Authors:
van Vollenhoven, R.; Seddighzadeh, M.; Jacobsen, S.; Dörner, T.; Ferraccioli, G.; Houssiau, F.; Huizinga, T.; Isenberg, D.; Lászlό, K.; Ruiz-Irastorza, G.; Squatrito, D.; Voskuyl, A.; Askanase, A.; Bernatsky, S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
539
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. THU0271 PERFORMANCE OF THE EULAR/ACR 2019 CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN EARLY DISEASE, ACROSS SEXES AND ETHNICITIES. (2nd June 2020)

Authors:
Johnson, S.; Brinks, R.; Costenbader, K.; Daikh, D.; Mosca, M.; Ramsey-Goldman, R.; Smolen, J. S.; Wofsy, D.; Boumpas, D.; Kamen, D. L.; Jayne, D.; Cervera, R.; Costedoat-Chalumeau, N.; Diamond, B.; Gladman, D. D.; Hahn, B. H.; Hiepe, F.; Jacobsen, S.; Khanna, D.; Lerstrom, K.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. FRI0155 Α MULTICENTER "AT-RISK" COHORT FOR THE DISCOVERY OF ENVIRONMENTAL, CLINICAL AND MOLECULAR PREDICTORS FOR THE TRANSITION INTO SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). (2nd June 2020)

Authors:
Adamichou, C.; Nikolopoulos, D.; Nikoloudaki, M.; Rahme, Z.; Fredi, M.; Pieta, A.; Repa, A.; Parma, A.; Kalogiannaki, E.; Avgustidis, N.; Kougkas, N.; Banos, A.; Eskitzis, A.; Bortoluzzi, A.; Jacobsen, S.; Sidiropoulos, P.; Dermitzakis, E.; Mosca, M.; Inês, L.; Andreoli, L.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
661
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗